About: Successful implementation of preventive measures leads to low relevance of SARS‐CoV‐2 in liver transplant patients: Observations from a German outpatient department

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Successful implementation of preventive measures leads to low relevance of SARS‐CoV‐2 in liver transplant patients: Observations from a German outpatient department Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Successful implementation of preventive measures leads to low relevance of SARS‐CoV‐2 in liver transplant patients: Observations from a German outpatient department
Creator	Pratschke, Johann Eurich, Dennis Globke, Brigitta Raul, Ramin Saidy, Ossami Schoening, Wenzel
source	Medline; PMC
abstract	BACKGROUND: Immunosuppressed liver transplant (LT) patients are considered to be at high risk for any kind of infection. What the outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) means for the transplant cohort is a question that, as of now, cannot easily be answered. Data on prevalence, relevance of the novel virus and clinical course of the infection in stable LT patients are limited. METHODS: Nasopharyngeal swabs were performed in our outpatient department during the shutdown between March and April 2020 in Germany. RESULTS: The prevalence of SARS‐CoV‐2 was 3%. Three out of a cohort of 101 LT‐patients were asymptomatic for respiratory diseases. Respiratory complaints were common and not associated with SARS‐CoV‐2 infection. The overall monthly mortality rate was 0,22% and did not show alterations during the shutdown in Germany. CONCLUSIONS: If preventive measures are applied, LT‐patients do not seem to be at a higher risk for SARS‐CoV‐2 infection. Telemedicine in the outpatient setting may help to maintain distance and to reduce direct patient contact. However, standard of care must be guaranteed for patients with relevant comorbidities in spite of pandemics, because complications may arise from preexisting conditions.
has issue date	2020-06-09(xsd:dateTime)
bibo:doi	10.1111/tid.13363
bibo:pmid	32516847
has license	no-cc
sha1sum (hex)	f0431f6a0dcd17568b02daa4342432104650afbd
schema:url	https://doi.org/10.1111/tid.13363
resource representing a document's title	Successful implementation of preventive measures leads to low relevance of SARS‐CoV‐2 in liver transplant patients: Observations from a German outpatient department
has PubMed Central identifier	PMC7300929
has PubMed identifier	32516847
schema:publication	Transpl Infect Dis
resource representing a document's body	covid:f0431f6a0dcd17568b02daa4342432104650afbd#body_text
is schema:about of	named entity 'measures' named entity 'German' named entity 'preventive' named entity 'SARS-CoV-2' named entity 'liver transplant' named entity 'immunosuppression' named entity 'everolimus' named entity 'Charité' named entity 'SARS-CoV-2' named entity 'COVID-19' named entity 'respiratory symptoms' named entity 'sensitive and specific' named entity 'immune reaction' named entity 'SARS-CoV-2' named entity 'WHO' named entity 'SARS-CoV-2' named entity 'immunosuppression' named entity 'HCV' named entity 'mortality rate' named entity 'cough' named entity 'immunocompromised patients' named entity 'fluorescence' named entity 'tacrolimus' named entity 'immunosuppression' named entity 'SARS-CoV-2' named entity 'outpatient clinic' named entity 'Liver transplant' named entity 'check-ups' named entity 'pediatric' named entity 'comorbidities' named entity 'SARS-CoV-2' named entity 'multi-organ failure' named entity 'April 2020' named entity 'comorbidities' named entity 'real-time PCR' named entity 'Germany' named entity 'autoimmune liver disease' named entity 'Germany' named entity 'SARS-CoV2' named entity 'telemedicine' named entity 'laryngopharyngeal' named entity 'biopsies' named entity 'median age' named entity 'SARS-CoV-2' named entity 'calcineurin inhibitors' named entity 'corticosteroids' named entity 'SARS-CoV-2' named entity 'medical attention' named entity 'infection rate' named entity 'prophylaxis' named entity 'case reports' named entity 'diabetes mellitus' named entity 'higher risk' named entity 'immunosuppression' named entity 'immunosuppression' named entity 'tracheobronchial' named entity 'long-term' named entity 'PBC' named entity 'quarantine' named entity 'respiratory symptoms' named entity 'eGFR' named entity 'COVID' named entity 'primary sclerosing cholangitis' named entity 'social distancing' named entity 'combination therapy' named entity 'high-risk' named entity 'PSC' named entity 'BMI' named entity 'ARDS' named entity 'chronic obstructive lung disease' named entity 'asymptomatic' named entity 'follow-up' named entity 'infection' named entity 'initial infection' named entity 'infection' named entity 'ARDS'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software